Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

Open Access 01-12-2021 | Research

RETRACTED ARTICLE: Post-operative blood pressure and 3-year major adverse cardiac events in Chinese patients undergoing PCI

Authors: Lijun Gan, Dandan Sun, Yuntao Cheng, Deyang Wang, Fen Wang, Lin Wang, Wei Li, Dandan Shen, Daotong Guo, Zonglei Zhang, Haiyan Wang, Jinli Li, Yong Yang, Tao Liang

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Background

There is no clear evidence for the target value of blood pressure control after Percutaneous coronary intervention (PCI). Therefore, our study was designed to explore the relationship between blood pressure after PCI and major adverse cardiac events (MACE) during 3-year follow-up.

Methods

This study is a prospective study. We included the patients who were diagnosed with acute coronary syndrome and underwent PCI stent implantation operation. The study initially collected information of 552 patients. The start and end times of the study are from January 1, 2017 to December 31, 2020. The independent variables of this study are the average systolic blood pressure and the average diastolic blood pressure after PCI. The dependent variable is the occurrence of MACE events in patients within 3 years after PCI. MACE is defined as acute myocardial infarction, recurring chest pain, heart failure, stroke, revascularization and cardiac death.

Results

A total of 514 subjects met the inclusion criteria. The average age of the study subjects is 61.92 ± 9.49 years old, of which 67.12% are male. 94 subjects had a MACE event within 3 years, and the occurrence rate was 18.29%. There is no significant non-linear or linear relationship between diastolic blood pressure and MACE events. There is a curvilinear relationship between the average systolic blood pressure of patients after PCI and MACE events within 3 years and the inflection point is 121. On the left side of the inflection point, the effect size and 95% CI are 1.09 and 1.01–1.18, respectively (P = 0.029). The impact size and 95% CI at the right inflection point were 1.00 and 0.98–1.02(P = 0.604), respectively.

Conclusion

There is a curvilinear relationship between systolic blood pressure and prognosis of patients after PCI. Under the premise of ensuring the safety of patients, maintaining lower blood pressure after surgery is beneficial to improve the prognosis of patients.
Literature
1.
go back to reference Nozue T, Yamamoto S, Tohyama S, et al. Impacts of conventional coronary risk factors, diabetes and hypertension, on coronary atherosclerosis during statin therapy: subanalysis of the TRUTH study. Coron Artery Dis. 2012;23(4):239–44.CrossRefPubMed Nozue T, Yamamoto S, Tohyama S, et al. Impacts of conventional coronary risk factors, diabetes and hypertension, on coronary atherosclerosis during statin therapy: subanalysis of the TRUTH study. Coron Artery Dis. 2012;23(4):239–44.CrossRefPubMed
2.
go back to reference Hall JE, Granger JP, Do CJ, et al. Hypertension: physiology and pathophysiology. Compr Physiol. 2012;2(4):2393–442.CrossRefPubMed Hall JE, Granger JP, Do CJ, et al. Hypertension: physiology and pathophysiology. Compr Physiol. 2012;2(4):2393–442.CrossRefPubMed
3.
go back to reference Lefèvre G, Puymirat E. Hypertension and coronary artery disease: new concept? Ann Cardiol Angeiol (Paris). 2017;66(1):42–7.CrossRefPubMed Lefèvre G, Puymirat E. Hypertension and coronary artery disease: new concept? Ann Cardiol Angeiol (Paris). 2017;66(1):42–7.CrossRefPubMed
4.
go back to reference Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.CrossRefPubMed Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.CrossRefPubMed
5.
go back to reference Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–115.PubMed Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–115.PubMed
6.
go back to reference Arima H, Barzi F, Chalmers J. Mortality patterns in hypertension. J Hypertens. 2011;29(Suppl 1):S3–7.CrossRefPubMed Arima H, Barzi F, Chalmers J. Mortality patterns in hypertension. J Hypertens. 2011;29(Suppl 1):S3–7.CrossRefPubMed
7.
go back to reference Redon J, Tellez-Plaza M, Orozco-Beltran D, et al. Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk study. J Hypertens. 2016;34(6):1075–83.CrossRefPubMed Redon J, Tellez-Plaza M, Orozco-Beltran D, et al. Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk study. J Hypertens. 2016;34(6):1075–83.CrossRefPubMed
8.
go back to reference Almgren T, Persson B, Wilhelmsen L, et al. Stroke and coronary heart disease in treated hypertension—a prospective cohort study over three decades. J Intern Med. 2005;257(6):496–502.CrossRefPubMed Almgren T, Persson B, Wilhelmsen L, et al. Stroke and coronary heart disease in treated hypertension—a prospective cohort study over three decades. J Intern Med. 2005;257(6):496–502.CrossRefPubMed
9.
go back to reference Pistoia F, Sacco S, Degan D, et al. Hypertension and stroke: epidemiological aspects and clinical evaluation. High Blood Press Cardiovasc Prev. 2016;23(1):9–18.CrossRefPubMed Pistoia F, Sacco S, Degan D, et al. Hypertension and stroke: epidemiological aspects and clinical evaluation. High Blood Press Cardiovasc Prev. 2016;23(1):9–18.CrossRefPubMed
10.
go back to reference Turin TC, Okamura T, Afzal AR, et al. Hypertension and lifetime risk of stroke. J Hypertens. 2016;34(1):116–22.CrossRefPubMed Turin TC, Okamura T, Afzal AR, et al. Hypertension and lifetime risk of stroke. J Hypertens. 2016;34(1):116–22.CrossRefPubMed
11.
go back to reference Redfors B, Chen S, Ben-Yehuda O, et al. Association between hypertension, platelet reactivity, and the risk of adverse events after percutaneous coronary intervention (From the ADAPT-DES Study). Am J Cardiol. 2019;124(9):1380–8.CrossRefPubMed Redfors B, Chen S, Ben-Yehuda O, et al. Association between hypertension, platelet reactivity, and the risk of adverse events after percutaneous coronary intervention (From the ADAPT-DES Study). Am J Cardiol. 2019;124(9):1380–8.CrossRefPubMed
12.
go back to reference Vidal-Petiot E, Ford I, Greenlaw N, et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet. 2016;388(10056):2142–52.CrossRefPubMed Vidal-Petiot E, Ford I, Greenlaw N, et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet. 2016;388(10056):2142–52.CrossRefPubMed
13.
go back to reference Franklin SS, Gokhale SS, Chow VH, et al. Does low diastolic blood pressure contribute to the risk of recurrent hypertensive cardiovascular disease events? The Framingham Heart Study. Hypertension. 2015;65(2):299–305.CrossRefPubMed Franklin SS, Gokhale SS, Chow VH, et al. Does low diastolic blood pressure contribute to the risk of recurrent hypertensive cardiovascular disease events? The Framingham Heart Study. Hypertension. 2015;65(2):299–305.CrossRefPubMed
14.
go back to reference Böhm M, Schumacher H, Teo KK, et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017;389(10085):2226–37.CrossRefPubMed Böhm M, Schumacher H, Teo KK, et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017;389(10085):2226–37.CrossRefPubMed
15.
go back to reference Komajda M, Böhm M, Borer JS, et al. Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT. Eur J Heart Fail. 2014;16(7):810–6.CrossRefPubMed Komajda M, Böhm M, Borer JS, et al. Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT. Eur J Heart Fail. 2014;16(7):810–6.CrossRefPubMed
16.
go back to reference Warren J, Nanayakkara S, Andrianopoulos N, et al. Impact of pre-procedural blood pressure on long-term outcomes following percutaneous coronary intervention. J Am Coll Cardiol. 2019;73(22):2846–55.CrossRefPubMed Warren J, Nanayakkara S, Andrianopoulos N, et al. Impact of pre-procedural blood pressure on long-term outcomes following percutaneous coronary intervention. J Am Coll Cardiol. 2019;73(22):2846–55.CrossRefPubMed
17.
go back to reference Shiraishi J, Nakamura T, Shikuma A, et al. Relationship between mean blood pressure at admission and in-hospital outcome after primary percutaneous coronary intervention for acute myocardial infarction. Int Heart J. 2016;57(5):547–52.CrossRefPubMed Shiraishi J, Nakamura T, Shikuma A, et al. Relationship between mean blood pressure at admission and in-hospital outcome after primary percutaneous coronary intervention for acute myocardial infarction. Int Heart J. 2016;57(5):547–52.CrossRefPubMed
18.
go back to reference Park H, Hong YJ, Cho JY, et al. Blood pressure targets and clinical outcomes in patients with acute myocardial infarction. Korean Circ J. 2017;47(4):446–54. CrossRefPubMedPubMedCentral Park H, Hong YJ, Cho JY, et al. Blood pressure targets and clinical outcomes in patients with acute myocardial infarction. Korean Circ J. 2017;47(4):446–54. CrossRefPubMedPubMedCentral
19.
go back to reference Finch W, Lee MS. Percutaneous coronary intervention for coronary bifurcation lesions. Rev Cardiovasc Med. 2017;18(2):59–66.CrossRefPubMed Finch W, Lee MS. Percutaneous coronary intervention for coronary bifurcation lesions. Rev Cardiovasc Med. 2017;18(2):59–66.CrossRefPubMed
21.
go back to reference Agyemang C, Bhopal RS. Is the blood pressure of South Asian adults in the UK higher or lower than that in European white adults? A review of cross-sectional data. J Hum Hypertens. 2002;16(11):739–51.CrossRefPubMed Agyemang C, Bhopal RS. Is the blood pressure of South Asian adults in the UK higher or lower than that in European white adults? A review of cross-sectional data. J Hum Hypertens. 2002;16(11):739–51.CrossRefPubMed
22.
go back to reference Pan H, Hibino M, Kobeissi E, et al. Blood pressure, hypertension and the risk of sudden cardiac death: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2020;35(5):443–54.CrossRefPubMed Pan H, Hibino M, Kobeissi E, et al. Blood pressure, hypertension and the risk of sudden cardiac death: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2020;35(5):443–54.CrossRefPubMed
23.
go back to reference Narayanan K, Reinier K, Teodorescu C, et al. Left ventricular diameter and risk stratification for sudden cardiac death. J Am Heart Assoc. 2014;3(5):e1193.CrossRef Narayanan K, Reinier K, Teodorescu C, et al. Left ventricular diameter and risk stratification for sudden cardiac death. J Am Heart Assoc. 2014;3(5):e1193.CrossRef
24.
go back to reference Shenasa M, Shenasa H. Hypertension, left ventricular hypertrophy, and sudden cardiac death. Int J Cardiol. 2017;237:60–3.CrossRefPubMed Shenasa M, Shenasa H. Hypertension, left ventricular hypertrophy, and sudden cardiac death. Int J Cardiol. 2017;237:60–3.CrossRefPubMed
25.
go back to reference Ogunsua AA, Shaikh AY, Ahmed M, et al. Atrial fibrillation and hypertension: mechanistic, epidemiologic, and treatment parallels. Methodist Debakey Cardiovasc J. 2015;11(4):228–34.CrossRefPubMedPubMedCentral Ogunsua AA, Shaikh AY, Ahmed M, et al. Atrial fibrillation and hypertension: mechanistic, epidemiologic, and treatment parallels. Methodist Debakey Cardiovasc J. 2015;11(4):228–34.CrossRefPubMedPubMedCentral
26.
go back to reference Shiraishi J, Kohno Y, Sawada T, et al. Prognostic impact of systolic blood pressure at admission on in-hospital outcome after primary percutaneous coronary intervention for acute myocardial infarction. J Cardiol. 2012;60(2):139–44.CrossRefPubMed Shiraishi J, Kohno Y, Sawada T, et al. Prognostic impact of systolic blood pressure at admission on in-hospital outcome after primary percutaneous coronary intervention for acute myocardial infarction. J Cardiol. 2012;60(2):139–44.CrossRefPubMed
27.
go back to reference Denardo SJ, Messerli FH, Gaxiola E, et al. Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]). Am J Cardiol. 2010;106(4):498–503.CrossRefPubMedPubMedCentral Denardo SJ, Messerli FH, Gaxiola E, et al. Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]). Am J Cardiol. 2010;106(4):498–503.CrossRefPubMedPubMedCentral
Metadata
Title
RETRACTED ARTICLE: Post-operative blood pressure and 3-year major adverse cardiac events in Chinese patients undergoing PCI
Authors
Lijun Gan
Dandan Sun
Yuntao Cheng
Deyang Wang
Fen Wang
Lin Wang
Wei Li
Dandan Shen
Daotong Guo
Zonglei Zhang
Haiyan Wang
Jinli Li
Yong Yang
Tao Liang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-02435-2

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue